Back to WELLS FARGO & COMPANY/MN WELLS FARGO & COMPANY/MN

AUTLAUTL
Showing 8 of 12 quarters

Position history for WELLS FARGO & COMPANY/MNWELLS FARGO & COMPANY/MN's holdings in AUTOLUS THERAPEUTICS LTD

WELLS FARGO & COMPANY/MN holds 212,592 shares of AUTL (AUTOLUS THERAPEUTICS LTD), worth $340,147 as of 2026-Q2. The position was increased (+2.3% shares). AUTL represents 0.0% of WELLS FARGO & COMPANY/MN's portfolio.

Current Value

$340,147

Current Shares

212,592

Total Value Change

-$1.1M

Total Shares Change

-173,281

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
212,592
+2.3%
$340,1470.0%$1.60
24
2026-Q1
Increased
207,856
+5.5%
$286,8420.0%$1.62
25
2025-Q4
Decreased
197,083
-14.7%
$392,1950.0%$1.97
0
2025-Q3
Decreased
231,132
-8.7%
$376,7460.0%$1.59
0
2025-Q2
Decreased
253,102
-3.1%
$577,0730.0%$2.31
0
2025-Q1
Decreased
261,146
-1.9%
$404,7760.0%$1.66
0
2024-Q4
Decreased
266,315
-31.0%
$625,8410.0%$2.21
0
2024-Q3
Increased
385,873
+1.5%
$1.4M0.0%$3.63
26

Other major holders of AUTL: Blackstone Inc., WELLINGTON MANAGEMENT GROUP LLP, Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used